Keqin F. Dong - Publications

Analysis of lymph node metastasis distribution patterns and dissection efficacy in thoracic esophageal cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 18, 2026

Long non-coding RNA LINC00092 inhibits esophageal squamous cell carcinoma progression by promoting ferroptosis through the MAZ/NFE2L2 axis.

Journal: Journal of thoracic disease

Published: November 21, 2025

Bioinformatic analysis and retrospective clinical study identifying DNAJB4 as a pan-cancer biomarker with a highlight on kidney cancer.

Journal: Clinical and experimental medicine

Published: May 28, 2025

Construction and validation of renal cell carcinoma tumor cell differentiation-related prognostic classification (RCC-TCDC): an integrated bioinformatic analysis and clinical study.

Journal: Annals of medicine

Published: April 18, 2025

A Pan-Cancer Analysis of Natriuretic Peptide Receptor 3 (NPR3) with Clinical Cohort and in vitro Validation.

Journal: Journal of inflammation research

Published: January 23, 2025

The comprehensive potential of AQP1 as a tumor biomarker: evidence from kidney neoplasm cohorts, cell experiments and pan-cancer analysis.

Journal: Human genomics

Published: December 22, 2024

Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 18, 2024

Construction of a prostate adenocarcinoma molecular classification: integrating spatial transcriptomics with retrospective cohort validation.

Journal: Journal of translational medicine

Published: November 19, 2024

Identification of Critical Phosphorylation Sites Enhancing Kinase Activity With a Bimodal Fusion Framework.

Journal: Molecular & cellular proteomics : MCP

Published: July 01, 2024

Unveiling the unique role of TSPAN7 across tumors: a pan-cancer study incorporating retrospective clinical research and bioinformatic analysis.

Journal: Biology direct

Published: April 28, 2024

CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression.

Journal: Cancer letters

Published: October 23, 2023

Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients.

Journal: International journal of medical sciences

Published: July 21, 2023